Pay in 4 interest-free payments of $5.49 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
TRPV1 Channel Inhibition: Research published in Molecular Immunology (2023) identified a second direct analgesic mechanism ARA-290 specifically inhibits TRPV1 (Transient Receptor Potential Vanilloid 1) channel activity in peripheral nociceptors, increasing the pain threshold and relieving mechanical hypersensitivity independent of its anti-inflammatory IRR actions
Very fast and efficient
Retrieved from (Archived content) RxList
Every order ships to the same standard: sterile-filled, precisely formulated, and documented, so your team can order with confidence and reorder without surprises
Potential Benefits & Side Effects Observations from preclinical and veterinary literature
Hussain K, Murdin L, Schilder AG
US$ 22.62
US$ 22.65
US$ 24.80
US$ 28.10
US$ 20.58
US$ 27.10
US$ 29.87
